M2BPGi

Haruki Uojima1,2, Kazumi Yamasaki3, Masaya Sugiyama4

  • 1Genome Medical Sciences Project, Research Institute, National Center for Global Health and Medicine, 1-7-1, Kohnodai, Ichikawa, Chiba, 272-8516, Japan. lb-uojima@hospk.ncgm.go.jp.

PubMed
概括

定量Mac-2-结合蛋白糖化异构体 (M2BPGi-Qt) 水平反映了慢性肝病 (CLD) 中的肝纤维化和炎症. 然而,肝炎可能会影响纤维化阶段的M2BPGi-Qt解释.